(Reuters) - New research shows more patients who got drug-coated stents right after suffering a severe heart attack later died from heart-related problems than those who received older, cheaper bare-metal models.Danish researchers conducted a trial of more than 600 patients examining the effectiveness and risks of the two types of stents implanted right after a major heart attack.
They found that after three years, patients who got bare-metal stents were more likely to have problems, such as requiring more intervention for blockages, while patients with the drug-coated variety were more likely to die from heart-related problems. Full Story
